Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Matthew Snape is a guest on Sierra Leone's radio programme Pikin to Pikin Tok.

Matthew discusses the work of the Department's vaccine group on Ebola vaccines on 'Pikin to Pikin Tok' (which means child to child talk in the local language Krio), a radio series launched during the Ebola crisis. You can listen to the programme here.

The UK child rights agency 'Child to Child' and their partner in Sierra Leone, 'the Pikin to Pikin movement' were running a project in the east of Sierra Leone (in the impoverished Kailahun region where the first case of Ebola was reported) since 2011. This project aimed to enhance children's social, literacy, numeracy and life skills, but the Ebola crisis meant that the NGO's work, which required children to come together in groups, had to stop due to the health risk such gatherings would create.

'Child to Child' decided to turn to radio and commissioned radio producer Penny Boreham, who also works for BBC World Service, to produce the programmes about staying healthy during the crisis and its aftermath.

The radio project, which broadcasts Storytime programmes, music programmes and special programmes like this one on the new Ebola vaccines, is funded by Comic Relief and presented by Sierra Leonean storyteller, Usifu Jalloh.

Similar stories

Oxford vaccine professor: rich countries have a moral duty to share their COVID-19 shots

COVID-19 Vaccinology

Andrew Pollard writes about vaccine equity in his article for The Conversation.

Increasing vaccine uptake among ethnic minorities

COVID-19 Public Engagement Vaccinology

Dr Samantha Vanderslott and Dr Seilesh Kadambari discuss their collaborative approach to providing ethnic minority groups with information on vaccines.

Human challenge trial launches to study immune response to COVID-19

COVID-19 Vaccinology

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

COVID-19 Clinical Trials Vaccinology

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

COVID-19 Vaccinology

Medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

AstraZeneca publish primary analysis from US trial of coronavirus vaccine

COVID-19 Vaccinology

Our partners AstraZeneca have today announced the high-level results from the primary analysis of their Phase III trial of the ChAdOx1 nCoV-19 coronavirus vaccine in the US. They confirm that the vaccine efficacy is consistent with the interim analysis results announced on Monday 22 March 2021.